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A B S T R A C T
Objective: to analyse maternal physiological changes in several areas (cardiovascular, metabolic, renal and he-
patic) related to the regular practice of a supervised exercise program.
Methods: This is an unplanned secondary analysis from a randomized controlled trial carried out in a single ma-
ternity unit in Madrid, Spain (NCT 02,756,143). From November 2014 to June 2015, 92 women were randomly
assigned to perform a mild-moderate supervised exercise program during pregnancy (Intervention group, IG) or
to continue with their routine pregnancy care (control group, CG). For the purpose of this study we collected
clinical and analytical data (heart blood pressure, weight, blood glucose, AST, ALT, blood Creatinine and blood
Uric acid) available from all obstetric visits and examined the differences between groups.
Results: We did not find any differences in: pregnancy weight (IG: 11.4 ± 4.4 Kg vs. CG: 10.1 ± 5.3 Kg;
p = 0.173); fasting glucose at 10+0–12+6 weeks (IG: 78.48±8.34 vs. CG: 76±13.26, p = 0.305) or at
34+0–36+4 weeks (IG: 73.25±10.27 vs CG: 73.45± 8.29,p = 0.920), and 50 gs glucose tolerance at
24+4–26+6weeks (IG: 116.23±35.07 vs CG: 116.36±25.98, p = 0.984); Aspartate-amino-transferase at
10+0–12+6 weeks (IG: 15.38±4.17 vs CG: 17.33±7.05, p = 0.124) and at 34+0–36+4 weeks (IG:
21.65±5.25 vs CG: 19.53±8.32, p = 0.165) or Alanine-amino- transferase at 10+0–12+6 weeks (IG:
27.50±10.63 vs CG: 28.27±11.77, p = 0.746) or at 34+0–36+4 weeks (IG: 22.93±9.23 vs CG: 20.84±13.49,
p = 0.407); blood Creatinine concentrations at 34+0–36+4 weeks (IG: 0.595±0.401 vs CG: 0.575±0.100,
p = 0.757) and blood uric acid concentrations at 34+0–36+4 weeks (IG: 3.526 ± 0.787 vs CG: 3.262±0.672,
p = 0.218). Heart blood pressure was similar between groups except at 27+0–28+6 weeks, where systolic
blood pressure was significantly lower in the CG in comparison to the IG (116.31±10.8 mmHg vs.
120.22 ± 10.3 mmHg, p = 0.010).
Conclusion: Regular supervised exercise during pregnancy does not alter normal maternal physiology.
1. Introduction
Regular exercise mediates several physiological modifications in the
human being, contributing to the prevention of several illnesses and to
the personal wellbeing. In order to prevent obesity and several cardio-
vascular and metabolic illness, the World Health Organization (WHO)
has published a guideline proposing the minimal activity recommended
according to ages [1].
Cardiovascular changes at rest have been described in pregnant
women that are under a supervised mild-moderate exercise program
during pregnancy, like lower heart rate levels or lower heart blood sys-
tolic and diastolic pressures [2–5]. This would reflect a positive adap-
tation of the maternal cardiovascular system to the exercise and it may
reduce the risk of preeclampsia during pregnancy [6].
Regarding metabolism, a good supply of nutrients is essential during
pregnancy [7]. Exercise increases the use of glucose by the muscles, and
it has been shown that a decrease in the blood glucose just occurs for
a short period of time during prenatal exercise and, more acutely dur-
ing the third trimester. Additionally, exercise during pregnancy elevates
circulating triglyceride levels [8]. It has been reported that acute exer-
cise in pregnant women, as opposed to choric exercise training, is associ-
ated with increased sympatho-adrenal and neurohumoral activity[7,9].
On the other hand, regular exercise, during pregnancy reduces glucose
levels at the screening test for gestational diabetes (50 gs Glucose Toler-
ance Test) at 24–28 weeks of gestation [10]. At renal level, no effect has
been concluded when performing moderate exercise during pregnancy
[8].
Most studies conclude that the regular practice of mild to moder-
ate exercise during pregnancy is not only safe but even positive for
both, the mother and
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the future new-born [4], although the underlying physiological changes
are not well established.
The aim of the present study was to analyse physiological changes
in the maternal cardiovascular, metabolic, renal and hepatic systems, in
relation to the regular practice of a supervised mild-moderate exercise
program. We hypothesized that this exercise during pregnancy would
not alter the normal maternal physiology.
2. Methods
2.1. Trial design and participants
This is an unplanned secondary analysis of a randomized controlled
trial (RCT), performed at the Hospital Universitario de Torrejon, Madrid,
Spain (NCT 02,756,143). A complete description of the design and meth-
ods of this RCT, was recently published [11]. Our main Objective was to
clarify if performing a supervised controlled exercise program through-
out pregnancy prevented excessive gestational weight gain. From No-
vember 2014 to June 2015, we included a total of 124 pregnant women.
Inclusion criteria were: (I) no obstetric complications according to
the American College of Obstetricians and Gynaecologists (ACOG)
guidelines [12], (II) gestational age at recruitment <16 weeks, (III) not
exercising regularly for more than 30 min (3 days per week), and (IV)
able to communicate in Spanish. Exclusion criteria were non-availabil-
ity to attend to the exercise program during pregnancy or not full filling
any of the inclusion criteria.
A simple randomisation was performed with the Epidat V.3.1 pro-
gram to allocate the participants into two groups in order of entry: inter-
vention group (IG) and control group (CG). For this, a computer-gener-
ated list of random numbers (n = 200) was created through the Epidat
option of balanced groups (similar but not of equal size). Unfortunately,
due to the lack of resources, the target number of participant could not
be achieved.
Trial coordinators regularly undertook quality control of data han-
dling, and verification of adherence to protocols.
The study was approved by the Local Research Ethics Committee
(CEIm Hospital Universitario Severo Ochoa) (19/07/2013). All women
gave written consent.
2.2. Maternal and pregnancy characteristics
We recorded the following maternal characteristics: maternal age,
maternal weight at 12+0–13+5 weeks and height, Body mass index
(BMI), racial origin (Caucasian vs non-Caucasian), method of conception
(natural or assisted conception), cigarette smoking during pregnancy
(yes or no), parity (parous or, according to previous delivery at ≥ 24
weeks’ gestation) and gestational age at delivery in days from the last
menstrual period calculated by ultrasound.
2.3. Control group
Pregnant women allocated to the CG were advised to do normal
daily activity and not to join any educational exercise program including
more than 30 min per day at least 3 times per week. The weekly volume
of physical activity was monitored by an exercise specialist at a final in-
terview at 38+0–39+6 weeks of gestation.
2.4. Intervention programme
The intervention programme was designed according to the 2015
ACOG standards and followed the structure of previous programme
studies [12–15]. It consisted in a supervised physical conditioning pro-
gramme of three-60-minutes-sessions per week during the whole preg-
nancy (from 12+3–15+6 weeks to 38+0–39+6 weeks of gestation) at
the Hospital gym. Women could attend any of the two evening sessions
we offered four days per week, up to a total of three. Each session in-
cluded 10 min of warming up, 25 min of cardiovascular exercise, 10 min
of strengthening exercises, 5 min of coordination and balance, 5 min
of pelvic floor exercises and 5 min of stretching and relaxation. Exer
cises in the supine position were not performed for more than 2 min.
Aerobic activity was prescribed at mild to moderate intensity, aiming
for 55–60% of maximum heart rate (HR). All women wore a HR moni-
tor (Polar FT7) during the training session to ensure that exercise inten-
sity was mild-moderate and the rating of perceived exertion scale ranged
from 12 to 14 (Somewhat Hard) [16].
Weekly volume of physical activity and the percentage of assistance
to the program were monitored all throughout the pregnancy by a qual-
ified exercise specialist trained in pre and postnatal exercise.
2.5. Follow-up
Once recruited, both groups had a similar follow-up at the Hos-
pital Universitario de Torrejon. Obstetric appointment took place at
12+0–13+5, 19+0–21+6, 27+0–28+6 and 35+0–36+6 weeks of gesta-
tion. Maternal blood pressure and maternal weight were checked in
every visit. Measurements taken at 12+0–13+5 week´s appointment
were considered as the baseline measurements. Patients were random-
ized until 15+6 weeks of gestation. All patients had a final interview
with the exercise specialist at 38+0–39+6 weeks´ gestation in other to
check their final weight and assess weekly volume of physical activity.
Routine blood routine tests were performed fasting at 10+0–12+6
and 34+0–36+4 weeks, and not fasting at 24+4–26+6 weeks, always in
the morning.
Microlife WatchBP Home blood pressure monitor was used for blood
pressure assessment. Blood pressure was measured after 5 min of rest in
a sitting position, with the arm resting at the level of the heart. Mater-
nal weight was measured in an automatic SECA scale. Blood samples for
glucose, Aspartate-amino-transferase (AST), Alanine-amino-transferase
(ALT), creatinine and uric acid, were analysed by Dimension EXL
(Siemens).
2.6. Study outcomes
Study outcomes were verified by one of three members of the re-
search team (I.F.B., M.B. or A.M.) and are summarized in the following
list according to the organ studied.
2.6.1. Cardiovascular
Maternal systolic and diastolic blood pressure measured in mmHg,
after 5 min of rest, in sitting resting position, in one arm at heart
level, checked at 12+0–13+5 (baseline), 19+0–21+6, 27+0–28+6 and
35+0–36+6 weeks in the obstetric appointment.
2.6.2. Metabolic and hepatic
Maternal weight measured (Kg), checked at 12+0–13+5 (baseline),
19+0–21+6, 27+0–28+6, 35+0–36+6 and at 38+0–39+6 (final weight).
Pregnancy weight gain was calculated as the final maternal weight mi-
nus the baseline weight.
Fasting blood glucose levels (mg/dl) were measured at the
10+0–12+6- and 34+0–36+4 weeks routing blood tests. Blood glucose
levels 60 min after a 50 mg Glucose Tolerance Test were measured at
the 24+4–26+6 weeks routine blood test.
Alanine-amino-transferase (ALT) and Aspartate-amino-transferase
(AST) were measured at the 10+0–12+6 and 34+0–36+4 weeks routine
blood test (UI/l) to asses hepatic function and amnio acid metabolism,
respectively.
2.6.3. Renal
Serum creatinine and uric acid levels (mg/dl) were determined at the
34+0–36+4 weeks routine blood test to asses renal function. Our proto-
col did not include any earlier analysis.
2.7. Statistical analysis
To describe demographic and clinical characteristics of patients,
data were expressed as mean (standard deviation) or median (interquar-
tile range), and proportions (absolute and relative frequencies) as ap-
propriate. Comparisons between treatment groups were performed by
unpaired t-Student test, Mann-Whitney U test or two-tailed χ2-test as
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ware package SPSS (IBM Corp. Released 2012. IBM SPSS Statistics for
Windows, Version 21.0. Armonk, NY: IBM Corp) was used for data
analysis.
3. Results
A total of 124 women were recruited and randomized into two
groups. Seventy pregnant women were randomised to the intervention
group (IG) and 54 to de control group (CG). Three women were ex-
cluded from the CG: one woman because of a late miscarriage at 20
weeks, other because of high-risk pregnancy (anti-kell antibodies), and
the third one withdrew consent after randomization. Additionally, one
woman from the IG had non available blood tests results. Twenty-eight
women from IG were not compliant with the programme and attended
<70% of the programme as requested by the study protocol. A per pro-
tocol analysis was finally made with the two final groups: IG (N = 41)
and CG (N = 51), as shown in the Trial Profile (Fig. 1).
The baseline characteristics were similar in both groups. Regarding
maternal age, pre-pregnancy BMI, parity, IVF pregnancy, ethnic, previ-
ous to pregnancy physical exercise and smoking, both groups were ho-
mogeneous (Table 1).
3.1. Cardiovascular outcomes
Both systolic and diastolic blood pressure were studied (Table 2)
and no differences were found except at 28 weeks, were systolic blood
pressure was lower in the CG compared to the IG (116.31 ± 10.8 mmHg
vs. 120.22 ± 10.3 mmHg, p = 0.010), but always within normal
ranges.
3.2. Metabolic and hepatic outcomes
The evolution through gestation of the maternal weight was analysed
and no differences were found between groups (Table 3).
When analysing maternal weight gain during pregnancy, no differ-
ence was found. However, there was a tendency for a lower mater-
nal weight at the end of the pregnancy in the IG compared to the CG
(10.1 ± 5 Kg vs. 11.4 ± 4 Kg, p = 0.173) (Table 3).
Fasting blood glucose level in the first and third trimester, blood glu-
cose after 50 mg glucose tolerance test, AST and ALT levels were similar
in both groups (Table 3).
3.3. Renal outcomes
Creatinine and uric acid concentrations in the third trimester were
similar in both groups (creatinine 0.57±0.1 mg/dl in the IG compared
to 0.59±0.4 mg/dl in the CG, p = 0.757; uric acid 3.26±0.6 mg/dl in
the IG compared to 3.45±0.7 mg/dl in the CG, p = 0.218) (Table 3).
4. Discussion
4.1. Main findings of the study
In this study we found that, first renal, metabolic and hepatic me-
tabolism was similar in pregnant women performing a moderated super-
vised exercise program compared to controls.
Second, although maternal blood pressure was similar between
groups, systolic blood pressure was higher at 27+0–28+6 weeks´in preg-
nant women performing a mild-moderated supervised exercise program
compared to controls.
And third, pregnancy weight gain tended to be lower in the exercise
group, although we were unable to prove significance.
4.2. Cardiovascular outcomes
Cardiovascular changes have been described in pregnant women un-
der a supervised exercise program during pregnancy [17,18]. Perales
et al. [19] described that, pregnant women under a supervised mild ex-
ercise program, have significant lower heart rate levels, lower blood sys-
tolic and diastolic pressure. Moreaver, a randomized controlled study
[5] found that aerobic exercise reduced resting systolic blood pressure
in normotensive pregnant women and reflected a positive adaptation of
the maternal cardiovascular system. Little is known about the mecha-
nism by which exercise may reduce blood pressure during pregnancy.
Exercise has been proposed to reduce oxidative stress, improve endothe-
lial function, as well as immune and inflammatory responses [20,21].
In addition, exercise is associated with an increase on the cardiac output
[21]. In our study we were unable to show this effect; in contrast, we
found the systolic blood pressure to be higher in the IG at 27+0–28+6
weeks. Since this finding sounds clinically implausible, we believe that
it merely reflects the result of performing multiple comparisons, more
than a real effect of the treatment, unless proven otherwise in another
study.
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Table 1
Demographic characteristics in both groups.
Data are given as mean and Standard deviation (SD) or n (%). Comparisons between out-








Maternal age (years) 33.17 (3.19) 32.63 (4.66) 0.510
Maternal 12 +0–13 +5 weeks
weight (Kg)
63.65 (10.90) 66.10 (14.56) 0.380
Maternal height (cm) 164.68 (6.89) 164.14 (5.84) 0.682
12 +0–13 +5 weeks BMI 22.81 (3.54) 23.80 (5.09) 0.293
IVF pregnancy 1 (2.4) 2 (3.9) 0.611
Caucasian 41 (100.0) 47 (92.2) 0.067
Pre-pregnancy physical
exercise
37 (90.2) 41 (80.4) 0.191
Nulliparous 31 (75.6) 38 (74.5) 0.904
Smoking 10 (24.4) 22 (43.1) 0.061
Gestation time at delivery
(days)
278.76 (9.45) 276.08 (11.45) 0.232
Table 2
Cardiovascular outcomes in both groups.
Data are given as mean (Standard deviation). Comparisons between outcome groups were
by chi, square test for categoric variables and Mann, Whitney U test for continuous vari-
ables.




(N = 51) p value
12 +0–13 +5
Week
120.54 (10.56) 119.51 (11.26) 0.656
19 +0–21 +6
Week
123.08 (8.99) 120.14 (14.10) 0.254
27 +0–28 +6
Week
122.20 (10.31) 116.31 (10.80) 0.010
35 +0–36 +6
Week
121.27 (8.49) 119.18 (14.60) 0.422




(N = 51) p value
12 +0–13 +5
Week
72.65 (8.70) 73.05 (7.20) 0.813
19 +0–21 +6
Week
72.96 (10.48) 72.25 (6.88) 0.712
27 +0–28 +6
Week
70.92 (11.03) 73.12 (6.90) 0.269
35 +0–36 +6
Week
75.33 (10.81) 74.46 (6.31) 0.653
4.3. Metabolic and hepatic outcomes
Maternal weight gain during pregnancy has an impact on the preg-
nancy and on the future newborn [22–33]. Previous meta-analysis have
demonstrated that exercise can help to prevent excessive weight gain
during pregnancy [34–36]. In our study, no differences were found in
maternal weight during each visit during pregnancy or in the maternal
weight gain at the end of the pregnancy, although a tendency to a lower
pregnancy weight gain could be observed in the intervention group. It
is true that if we could stratify by basal BMI we may see more pro-
nounced differences in the higher basal BMI group, as demonstrated by
some studies [12,37–44], but this sub-group analysis was not possible
due to the small sample size.
Glucose is essential for foetal wellbeing [7]. Exercise increases the
capitation of glucose by the muscles, and therefore we could argue that
the hypoglycaemia that occurs during exercising mothers may influence
foetal growth or development. However, our results show no differences
in the basal fasting glucose levels between groups. On the other hand,
Barakat et al. [10] and Deierlein et al. [45] concluded that regular ex-
ercise during pregnancy reduces glucose levels at the screening test for
gestational diabetes at 24–28 weeks of gestation (50 g Glucose Toler-
ance Test), but our results were are not consistent with this finding. This
may be due to the fact that our pregnant women were advised to have
a light breakfast before attending the test, while in these studies the test
was performed fasting. Some studies suggest that exercise during preg
Table 3
Metabolic, Hepatic and renal outcomes in both groups.
Data are given as mean (Standard deviation). Comparisons between outcome groups were









12 +0–13 +5 Week 64.89 (11.15) 64.34 (18.65) 0.867
19 +0–21 +6 Week 67.96 (10.66) 70.11 (14.50) 0.430
27 +0–28 +6 Week 71.46 (11.13) 73.66 (14.70) 0.429
35 +0–36 +6 Week 74.48 (11.54) 76.85 (15.05) 0.411
38 +0–39 +6 Week 75.15 (11.57) 76.25 (15.47) 0.705
Maternal weight
gain
10.153 (5.39) 11.49 (4.43) 0.173
Glucose (mg/dl)
Intervention





10 +0–12 +6 Week 78.48 (8.34) 76.00 (13.26) 0.305
24 +4–26 +6 Week, 50 g
Glucose Tolerance Test
116.23 (35.07) 116.36 (25.98) 0.984





(N = 51) p value
10 +0–12 +6
Week
15.38 (4.17) 17.33 (7.05) 0.124
34 +0–36 +4
Week





(N = 51) p value
10 +0–12 +6
Week
27.50 (10.63) 28.27 (11.77) 0.746
34 +0–36 +4
Week





(N = 51) p value
34 +0–36 +4
Week





(N = 51) p value
34 +0–36 +4
Week
3.526 (0.787) 3.262 (0.672) 0.218
nancy does not prevent from gestational diabetes but can help to control
glucose levels in diabetic pregnant women [46–48]. In our study, only
one woman developed gestational diabetes in the CG, and therefore no
comparison could be carried out at this level.
Regarding the hepatic metabolism, it has been described that exer-
cise increases the levels of AST and its activity [49,50]. During preg-
nancy, it has not been determined how exercise could affect AST and
ALT yet. Our results show no statistical changes in the hepatic enzymes
during pregnancy in those women exercising compared to controls.
4.4. Renal outcomes
At a renal level, there is no significant effect when performing
mild-moderate exercise during pregnancy [8], although it is not clear
whether urinary urea nitrogen excretion could be affected by the exer-
cise [51]. Our results at this point are consistent with this finding, but
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4.5. Study strengths and limitations
The main strength of our study resides in being a randomized con-
trolled study with multiple timepoints check-ups. Additionally, the
guidelines for exercise followed here are internationally recommended.
On the other hand, the main limitation is the small sample size which
may be reason for the lack of beneficial results and did not allow us to
perform sub-group analyses. Some may argue that increasing exercise
intensity may cause a greater impact, however, high-intensity exercise
during pregnancy is related to adverse obstetric outcomes and therefore
not recommended [52–56]. Another limitation is the increased propor-
tion of nulliparous women compared to the general low risk pregnant
population, which could represent a selection bias. However, parity has
not been demonstrated as a risk factor for any of the variables studied.
Finally, our study included only low-risk pregnancies and therefore our
results might not be valid for a different population.
5. Conclusions
A regular supervised mild-moderate exercise programme during
pregnancy does not impact the normal physiological changes that oc-
cur during pregnancy. However, further and larger studies are needed to
confirm our findings.
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